AMC3 MED.B.095 Medical examination and assessment of applicants for LAPL medical
certificates
ED Decision 2019/002/R
(a) Applicants should undergo pulmonary morphological or functional tests when clinically indicated.
(b) Asthma and chronic obstructive pulmonary disease
Applicants with asthma or impairment of pulmonary function may be assessed as fit provided that the condition is considered stable with satisfactory pulmonary function and medication is compatible with flight safety. Systemic steroids may be acceptable provided that the dosage required is acceptable and there are no adverse side effects.
(1) Applicants with active sarcoidosis should be assessed as unfit. Investigation should be undertaken with respect to the possibility of systemic involvement. A fit assessment may be considered once the disease is inactive.
(2) Applicants with cardiac sarcoidosis should be assessed as unfit.
(1) Applicants with spontaneous pneumothorax may be assessed as fit subject to satisfactory respiratory evaluation following recovery from a single spontaneous pneumothorax or following recovery from surgical intervention for a recurrent pneumothorax.
(2) Applicants with traumatic pneumothorax may be assessed as fit following recovery.
Applicants who have undergone thoracic surgery may be assessed as fit following recovery.
(f) Sleep apnoea syndrome/sleep disorder
Applicants with unsatisfactorily treated sleep apnoea syndrome should be assessed as unfit.
LAPL medical certificate applicants require respiratory system evaluation. Asthma, COPD, and pneumothorax may be acceptable with stable conditions and safe medication. Active sarcoidosis and cardiac sarcoidosis are disqualifying. Post-thoracic surgery and traumatic pneumothorax require recovery. Untreated sleep apnea leads to unfitness for flight.
* Summary by Aviation.Bot - Always consult the original document for the most accurate information.
Loading collections...